NTHI (STOCKS)
NeOnc Technologies Holdings, Inc. Common Stock
$4.510000
-0.240000 (-5.05%)
Prev close: $4.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Amir Farrokh Heshmatpour
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $117.32M
- Employees
- 5
- P/E (TTM)
- -2.45
- P/B (TTM)
- -8.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.35 | $-0.22 | -0.1256 | -55.97% |
|
Dec 2025 (Q4)
|
$-0.73 | $-0.38 | -0.3526 | -93.43% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $33.40M |
| Research and Development | $3.93M |
| Other Operating Expenses | $29.47M |
| Operating Income/Loss | -$33.40M |
| Income/Loss From Continuing Operations After Tax | -$38.64M |
| Income/Loss From Continuing Operations Before Tax | -$38.64M |
| Interest Expense, Operating | $3.18M |
| Net Income/Loss | -$38.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.85 |
| Diluted Earnings Per Share | -$1.85 |
| Basic Average Shares | 62,143,147 |
| Diluted Average Shares | 62,143,147 |
| Assets | $3.33M |
| Current Assets | $2.10M |
| Noncurrent Assets | $1.23M |
| Liabilities | $16.56M |
| Current Liabilities | $16.29M |
| Noncurrent Liabilities | $273.71K |
| Equity | -$13.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$13.23M |
| Liabilities And Equity | $3.33M |
| Net Cash Flow From Operating Activities | -$21.71M |
| Net Cash Flow From Operating Activities, Continuing | -$21.71M |
| Net Cash Flow From Investing Activities | $4.80M |
| Net Cash Flow From Investing Activities, Continuing | $4.80M |
| Net Cash Flow From Financing Activities | $16.91M |
| Net Cash Flow From Financing Activities, Continuing | $16.91M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$38.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.64M |
| Other Comprehensive Income/Loss | $0.00 |